- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Results
106
Most Popular Stocks on the market
106 companies
TOT BIOPHARM International
Market Cap: HK$1.3b
An investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in China.
1875
HK$1.73
7D
1.2%
1Y
11.6%
Brii Biosciences
Market Cap: HK$1.3b
Engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.78
7D
9.9%
1Y
71.2%
Genor Biopharma Holdings
Market Cap: HK$1.1b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$2.06
7D
3.0%
1Y
79.1%
Wuhan YZY Biopharma
Market Cap: HK$901.4m
A biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related eye diseases.
2496
HK$4.65
7D
-21.2%
1Y
-37.6%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$896.4m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.60
7D
-4.8%
1Y
-11.1%
3D Medicines
Market Cap: HK$874.8m
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the Mainland China.
1244
HK$3.57
7D
1.7%
1Y
-35.8%
HighTide Therapeutics
Market Cap: HK$849.4m
An investment holding company, engages in the discovery, research and development, and commercialization of therapies for the treatment of metabolic and digestive diseases in Mainland China.
2511
HK$1.65
7D
16.2%
1Y
-66.8%
Zhaoke Ophthalmology
Market Cap: HK$819.2m
An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong.
6622
HK$1.50
7D
4.2%
1Y
-3.2%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$768.6m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.89
7D
-2.2%
1Y
-25.8%
Lee's Pharmaceutical Holdings
Market Cap: HK$753.7m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.28
7D
4.9%
1Y
10.3%
Pak Fah Yeow International
Market Cap: HK$710.5m
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.28
7D
0.4%
1Y
11.2%
Sunho Biologics
Market Cap: HK$655.4m
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems.
2898
HK$4.35
7D
5.3%
1Y
n/a
JW (Cayman) Therapeutics
Market Cap: HK$587.6m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China.
2126
HK$1.45
7D
-2.0%
1Y
-15.7%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$495.0m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.29
7D
9.3%
1Y
86.7%
Kintor Pharmaceutical
Market Cap: HK$476.3m
A clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications with the unmet medical needs in the People’s Republic of China.
9939
HK$1.10
7D
-1.8%
1Y
26.4%
Transcenta Holding
Market Cap: HK$464.9m
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$1.15
7D
-2.5%
1Y
-31.5%
Austar Lifesciences
Market Cap: HK$410.1m
An investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.80
7D
-1.2%
1Y
-20.0%
Uni-Bio Science Group
Market Cap: HK$406.0m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.068
7D
1.5%
1Y
-18.1%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$360.0m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.32
7D
-5.9%
1Y
31.7%
Tianda Pharmaceuticals
Market Cap: HK$339.7m
Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
455
HK$0.16
7D
16.2%
1Y
-39.2%
Sirnaomics
Market Cap: HK$308.9m
An RNA therapeutics biopharmaceutical company, discovers and develops product candidates for indications with medical needs.
2257
HK$2.96
7D
-3.9%
1Y
-49.0%
Clover Biopharmaceuticals
Market Cap: HK$254.2m
A biotechnology company, engages in the research and development, manufacture, and commercialization of vaccines in Mainland China.
2197
HK$0.20
7D
-3.0%
1Y
-39.7%
Modern Chinese Medicine Group
Market Cap: HK$243.0m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.41
7D
14.1%
1Y
26.6%
PuraPharm
Market Cap: HK$185.7m
An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.
1498
HK$0.47
7D
-5.1%
1Y
-37.3%
China NT Pharma Group
Market Cap: HK$182.0m
Engages in the investment, research and development, manufacturing, sales, and distribution of pharmaceutical products in the People’s Republic of China.
1011
HK$0.27
7D
20.5%
1Y
28.6%
Fusen Pharmaceutical
Market Cap: HK$181.9m
An investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.
1652
HK$0.25
7D
0.4%
1Y
-71.1%
China Health Group
Market Cap: HK$142.3m
An investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.
8225
HK$0.14
7D
0.7%
1Y
31.2%
China Regenerative Medicine International
Market Cap: HK$129.3m
An investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.42
7D
46.6%
1Y
51.8%
Kontafarma China Holdings
Market Cap: HK$128.5m
An investment holding company, engages in the manufacture and sale of prescription drugs in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.023
7D
-8.0%
1Y
-32.4%
Extrawell Pharmaceutical Holdings
Market Cap: HK$109.9m
An investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People’s Republic of China and Hong Kong.
858
HK$0.046
7D
-2.1%
1Y
64.3%
Regent Pacific Group
Market Cap: HK$108.5m
An investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.
575
HK$0.47
7D
6.7%
1Y
11.8%
Biosino Bio-Technology and Science Incorporation
Market Cap: HK$78.1m
Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
8247
HK$0.54
7D
-1.8%
1Y
-22.9%
CANbridge Pharmaceuticals
Market Cap: HK$62.0m
A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.
1228
HK$0.15
7D
-16.6%
1Y
-54.4%
Sanai Health Industry Group
Market Cap: HK$48.9m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.32
7D
3.2%
1Y
-54.3%